July 21, 2022
1 min read

BA.5 Omicron subvariant now dominant in US

The BA.5 subvariant accounted for 77.9 per cent of new infections in the week ending July 16, up from 68.7 per cent a week before…reports Asian Lite News

The BA.5 Omicron subvariant, now the dominant coronavirus strain in the US, made up nearly 80 per cent of new Covid-19 infections in the country, according to latest data from the Centers for Disease Control and Prevention (CDC).

The BA.5 subvariant accounted for 77.9 per cent of new infections in the week ending July 16, up from 68.7 per cent a week before, Xinhua news agency reported.

Another new subvariant, BA.4, accounted for 12.8 per cent of new infections, CDC data show.

The two contagious subvariants now made up over 90 per cent of new infections in the US.

Confirmed cases contracted by the two subvariants kept increasing since mid-May, CDC data show.

The two subvariants are more contagious than earlier variants of Omicron, and also appear to evade protection from vaccines and previous infections more easily than most of their predecessors, according to health experts

ALSO READ: Heat wave sweeps US

Previous Story

Wickremesinghe swears-in

Next Story

Spain rejects EU gas usage proposal

Previous Story

Wickremesinghe swears-in

Next Story

Spain rejects EU gas usage proposal

Latest from -Top News

Jaishankar meets Azerbaijan President to strengthen ties

Friday to discuss strengthening bilateral relations. The visit comes amid renewed diplomatic engagement between the two countries, with officials highlighting historical links and opportunities to expand cooperation…reports Asian Lite News Desk Jaishankar

China, Iran Mark Decade of Strategic Partnership

Chinese Premier Li Qiang met Iran’s First Vice President Mohammad-Reza Aref in Dushanbe as China and Iran marked 10 years of their comprehensive strategic partnership…reports Asian Lite News Desk Chinese Premier Li
Go toTop

Don't Miss

Big setback for Trump

There was a large crowd of demonstrators outside the courthouse

Teva Pharma found liable in Opioid crisis

The drug maker argued at trial that it complied with